Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial is studying the side effects and best dose of azacitidine when given
together with entinostat and to see how well they work in treating patients with recurrent
advanced non-small cell lung cancer. Azacitidine and entinostat may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth. Giving azacitidine together
with entinostat may kill more tumor cells.